Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Growth Metrics

HealthLynked (HLYK) Long-Term Investments (2021 - 2022)

HealthLynked (HLYK) has disclosed Long-Term Investments for 2 consecutive years, with $300600.0 as the latest value for Q4 2022.

Quarterly Long-Term Investments changed 0.0% to $300600.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $300600.0 through Dec 2022, changed 0.0% year-over-year, with the annual reading at $300600.0 for FY2022, 0.0% changed from the prior year.
Long-Term Investments for Q4 2022 was $300600.0 at HealthLynked, up from $255000.0 in the prior quarter.
The five-year high for Long-Term Investments was $300600.0 in Q4 2021, with the low at $165000.0 in Q1 2022.